Pfizer and CDRD Ventures Inc. (CVI), the commercialization department of The Centre for Drug Research and Development (CDRD), have entered a strategic collaboration aimed at providing new resources to advance innovative and therapeutically promising health technologies towards commercialization in Canada.   Pfizer will have the opportunity to support mutually-selected CVI R&D projects with the goal of commercializing the programs and resulting intellectual property. This collaboration follow...